Telavancin

From WikiMD's Wellnesspedia

Telavancin


Telavancin is a lipoglycopeptide antibiotic used in the treatment of certain bacterial infections. It is a semi-synthetic derivative of vancomycin, and was approved by the FDA in 2009.

Mechanism of Action[edit | edit source]

Telavancin inhibits cell wall synthesis in bacteria by binding to the D-alanyl-D-alanine terminus of the cell wall precursor lipid II. This prevents the incorporation of lipid II into the growing bacterial cell wall, leading to cell death. Telavancin also disrupts bacterial cell membrane function, which contributes to its bactericidal activity.

Clinical Use[edit | edit source]

Telavancin is indicated for the treatment of skin and skin structure infections caused by susceptible Gram-positive bacteria, including MRSA. It is also used in the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by Staphylococcus aureus, including MRSA.

Side Effects[edit | edit source]

Common side effects of telavancin include nausea, vomiting, and diarrhea. Serious side effects can include kidney damage, QT interval prolongation, and Clostridium difficile infection.

Pharmacokinetics[edit | edit source]

Telavancin is administered intravenously. It has a half-life of approximately 8 hours and is primarily excreted in the urine.

See Also[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD